• 10 Hits
  • Search Condition : Filter (MeSH = Adenocarcinoma, Clear Cell / metabolism)
Species Resource Title
Human and Animal Cells JHOC-7(RCB1688) , JHOC-9(RCB2226) MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Human and Animal Cells JHOC-9(RCB2226) Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
Human and Animal Cells JHOC-5(RCB1520) Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.
Human and Animal Cells JHOC-5(RCB1520) PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Human and Animal Cells JHOC-5(RCB1520) Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Human and Animal Cells Hyalinized stroma in clear cell carcinoma of the ovary: how is it formed?
Human and Animal Cells OMC-3(RCB0755) , JHOC-5(RCB1520) , HTOA(RCB0692) , JHOS-3(RCB1546) Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis.
Human and Animal Cells IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
Human and Animal Cells NIH:OVCAR-3(RCB2135) Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.